Exploring how genetic mutations and RNA variations impact health and disease
Understanding how structural mutations and individual RNA isoforms are involved in human health and disease
This study is looking at how changes in our genes and different types of RNA might affect health issues like autism and cancer, with the goal of creating more personalized treatments that work better for each person, especially considering differences between men and women.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-10894684 on NIH RePORTER |
What this research studies
This research investigates the role of structural mutations in the genome and individual RNA isoforms in various health conditions, including autism and cancer. By analyzing how these genetic factors contribute to diseases, the study aims to personalize medicine by moving beyond standard reference genomes. The approach combines genomic sequencing with RNA isoform analysis to better understand the biological differences that may affect treatment outcomes, particularly considering variations between sexes. This research could lead to more tailored therapies based on individual genetic profiles.
Who could benefit from this research
Good fit: Ideal candidates include individuals with conditions such as autism, cancer, Crohn's disease, or other genetic disorders.
Not a fit: Patients without genetic mutations or those with conditions not related to the focus areas of this research may not benefit.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with genetic disorders and diseases.
How similar studies have performed: Other research has shown promise in understanding genetic mutations and RNA variations, suggesting that this approach could yield significant insights.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Ebbert, Mark T W — University of Kentucky
- Study coordinator: Ebbert, Mark T W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.